Cindy L O'Bryant

Years Active: 2021-2024
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

S Lindsey Davis, Wells A Messersmith, W Thomas Purcell, Elaine T Lam, Bradley R Corr, Alexis D Leal, Christopher H Lieu, Cindy L O'Bryant, Stephen G Smoots, Evan D Dus, Kimberly R Jordan, Natalie J Serkova, Todd M Pitts, Jennifer R Diamond
A Phase Ib Expansion Cohort Evaluating Aurora A Kinase Inhibitor Alisertib and Dual TORC1/2 Inhibitor Sapanisertib in Patients with Advanced Solid Tumors. Cancers 16 (8) (2024)
S Lindsey Davis, Wells A Messersmith, W Thomas Purcell, Elaine T Lam, Bradley R Corr, Alexis D Leal, Christopher H Lieu, Cindy L O'Bryant, Stephen G Smoots, Evan D Dus, Kimberly R Jordan, Natalie J Serkova, Todd M Pitts, Jennifer R Diamond
A Phase Ib Expansion Cohort Evaluating Aurora A Kinase Inhibitor Alisertib and Dual TORC1/2 Inhibitor Sapanisertib in Patients with Advanced Solid Tumors. Cancers 16 (8) (2024)
Mehmet Akce, Anthony El-Khoueiry, Sarina A Piha-Paul, Emeline Bacque, Peng Pan, Zhi-Yi Zhang, Reginald Ewesuedo, Divya Gupta, Yongqiang Tang, Ashley Milton, Stefan Zajic, Patricia L Judson, Cindy L O'Bryant
Pharmacokinetics and safety of niraparib in patients with moderate hepatic impairment. Cancer chemotherapy and pharmacology 88 (5) (2021)

Cindy L O'Bryant.css-eqlu8i{font-size:small;padding-left:4px;}